News | April 27, 2009

Varian to Show Brachytherapy, IMRT, SBRT at AUA Meeting

April 27, 2009 - Varian Medical Systems is showcasing the its full spectrum of prostate cancer treatment technologies, including brachytherapy, IMRT and SBRT, at the American Urological Association (AUA) Meeting at McCormick Place in Chicago from April 25-30.

"At the AUA meeting, we'll be exhibiting our latest solutions for high-dose-rate brachytherapy, planning for low-dose brachytherapy with permanent seed implants, 3D conformal radiotherapy, intensity-modulated radiotherapy (IMRT), and stereotactic body radiotherapy (SBRT)," said Calvin Huntzinger, MS, senior director, Varian Surgical Sciences. Each is a different approach to targeting prostate tumors with radiation.

Varian recently produced a clinical perspectives paper entitled “Early-stage prostate cancer treatment alternatives,” highlighting research that contrasts these and other approaches to prostate cancer treatment.

Varian will be showcasing the following radiotherapy solutions at the AUA meeting:

- The VariSource and GammaMed lines of HDR brachytherapy afterloaders, a computer-controlled device for guiding a needle or catheter as it places a radiation source directly into a tumor and holds it there for a prescribed period of time while the dose is delivered.
- VariSeed brachytherapy treatment planning software, which facilitates the permanent implantation of tiny radioactive seeds, each the size of a grain of rice, directly into the prostate.

Also showcased will be the Novalis Tx platform for image-guided radiotherapy and radiosurgery, a suite of tools made by Varian and BrainLAB for delivering external beam radiotherapies, including 3D conformal, IMRT, RapidArc radiotherapy and SBRT.

Novalis Tx can also deliver RapidArc radiotherapy, making it possible to complete an IMRT or SBRT treatment very quickly by dosing the entire tumor volume with a single rotation of the treatment machine around the patient.

The American Urological Association Meeting will take place at McCormick Place in Chicago, April 25-30.

For more information: www.varian.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation